Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptifibatide for prevention of periprocedural myocardial necrosis during elective PCI in stable angina
2008-000515-14Phase 3Terminated
- Sponsor
- Azienda Sanitaria Locale 9 di Grosseto
- Start
- Nov 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of eptifibatide and heparin in angina pectoris and coronary arteriosclerosis (2 arms), sponsored by Azienda Sanitaria Locale 9 di Grosseto. Started Nov 2008; status: terminated.
02
Drugs
eptifibatideheparin
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on 2008-000515-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000515-14.